EQUITY Equity (Tables)
|
9 Months Ended |
Sep. 30, 2024 |
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the nine months ended September 30, 2024: | | | | | | | | | | | | | | | | | | | Cash Flow Hedge | | Foreign Currency Items | | Total | | (in thousands) | | Balance at December 31, 2023 | $ | 29,350 | | | $ | (1,900) | | | $ | 27,450 | | Other comprehensive income (loss) before reclassifications | 3,320 | | | (191,011) | | | (187,691) | | | Amount reclassified from AOCI | (14,370) | | | — | | | (14,370) | | | Net other comprehensive loss | (11,050) | | | (191,011) | | | (202,061) | | | Balance at September 30, 2024 | $ | 18,300 | | | $ | (192,911) | | | $ | (174,611) | |
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2024 | | 2023 | | 2024 | | 2023 | | | | Weighted average common shares—basic | 230,374,307 | | | 228,787,263 | | | 229,923,989 | | | 228,497,712 | | | Effect of dilutive securities: | | | | | | | | | Stock options and restricted stock | 1,941,001 | | | 2,371,755 | | | 2,226,003 | | | 2,252,391 | | | Convertible senior notes | 13,004,660 | | | 13,004,660 | | | 3,778,760 | | | 4,396,292 | | | Weighted average common shares—diluted | 245,319,968 | | | 244,163,678 | | | 235,928,752 | | | 235,146,395 | |
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income per common share because such securities are anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2024 | | 2023 | | 2024 | | 2023 | | Options to purchase shares of common stock | — | | | 3,750 | | | 3,750 | | | 3,750 | | | Restricted stock and deferred stock—unvested | 2,147,167 | | | 2,361,832 | | | 2,162,662 | | | 2,430,242 | | | | | | | | | | | Conversion shares related to the convertible senior notes | — | | | — | | | 9,225,900 | | | 8,921,749 | | | Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding | 2,147,167 | | | 2,365,582 | | | 11,392,312 | | | 11,355,741 | |
|